| Literature DB >> 33302345 |
Alessandra Galli1, Paola Marciani1, Algerta Marku1, Silvia Ghislanzoni1, Federico Bertuzzi2, Raffaella Rossi3, Alessia Di Giancamillo3, Michela Castagna1, Carla Perego1.
Abstract
Substantial epidemiological evidence indicates that a diet rich in polyphenols protects against developing type 2 diabetes. The phenylethanoid glycoside verbascoside/acteoside, a widespread polyphenolic plant compound, has several biological properties including strong antioxidant, anti-inflammatory and neuroprotective activities. The aim of this research was to test the possible effects of verbascoside on pancreatic β-cells, a target never tested before. Mouse and human β-cells were incubated with verbascoside (0.8-16 µM) for up to five days and a combination of biochemical and imaging techniques were used to assess the β-cell survival and function under normal or endoplasmic reticulum (ER)-stress inducing conditions. We found a dose-dependent protective effect of verbascoside against oxidative stress in clonal and human β-cells. Mechanistic studies revealed that the polyphenol protects β-cells against ER-stress mediated dysfunctions, modulating the activation of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) branch of the unfolded protein response and promoting mitochondrial dynamics. As a result, increased viability, mitochondrial function and insulin content were detected in these cells. These studies provide the evidence that verbascoside boosts the ability of β-cells to cope with ER-stress, an important contributor of β-cell dysfunction and failure in diabetic conditions and support the therapeutic potential of verbascoside in diabetes.Entities:
Keywords: ER-stress; PERK; UPR; anti-inflammatory; diabetes; insulin-producing cells; mitochondria; oxidative stress; polyphenols; verbascoside
Year: 2020 PMID: 33302345 PMCID: PMC7762434 DOI: 10.3390/biomedicines8120582
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059